abstract |
The present invention relates to a method for identifying a risk for subsequent cardiovascular events in a patient suffering from acute coronary syndromes (e.g., cardiovascular disease-causing death, non-fatal myocardial infarction, ischemic stroke, unstable angina pectoris, And methods (including detecting levels of NT-proBNP, homocysteine and CRP). |